Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes (2019)
Attributed to:
Type 1 diabetes genetic risk and persistent beta cell enteroviral infection - a lethal combination?
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00125-019-4811-7
PubMed Identifier: 30675626
Publication URI: http://europepmc.org/abstract/MED/30675626
Type: Journal Article/Review
Parent Publication: Diabetologia
Issue: 5
ISSN: 0012-186X